TruScreen raises $4.09M from institutions to fund growth, plans retail share offer

TruScreen raises $4.09M from institutions to fund growth, plans retail share offer
Tina Morrison
By Tina Morrison March 22 (BusinessDesk) - TruScreen, the NZAX-listed cervical cancer test developer, raised $4.09 million in a share sale to institutional and other select investors to strengthen its balance sheet and fund future growth. The Auckland-based company sold 25,562,500 shares at 16 cents apiece, a discount to its last traded price of 17 cents. It plans to make the same offer to existing retail shareholders, who will be able to subscribe for shares at 16 cents apiece, it said in a statement. TruScreen is raising money to str...